 paralysis treatment neuromuscular junction agents OBJECTIVES Previous reports prolonged paralysis treatment neuromuscular junction agents ill patients purpose study group patients prolonged weakness treatment agents DESIGN Clinical information electrodiagnostic muscle pathology results group patients Clinical information diagnoses dosage neuromuscular junction blocker medications neuromuscular system neuromuscular examination clinical course SETTING patients ICUs local hospitals PATIENTS ill patients variety diagnoses severe weakness discontinuation neuromuscular junction agents INTERVENTIONS Electrodiagnostic studies muscle biopsies several patients MEASUREMENTS MAIN RESULTS patients weakness sensory loss Electrodiagnostic muscle pathology findings consistent failed neuromuscular transmission many patients disorders medications neuromuscular system disorder medication common Recovery strength several months patients slow mechanical ventilator support CONCLUSIONS alternative explanations certainty use neuromuscular junction agents neurogenic atrophy care